Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | — | IM |
Pt was offered and received 1 dose of Bexero although she is under 16 and does not meet high risk requirements for recommendation of Men B vaccine for someone under 16 yrs old.
none
intellectual disability, developmental delay
ceterizine, miralax, naproxen
none
No adverse events, just received vaccine inappropriate for pt's age and medical history